Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof

Patent No. EP2461802 (titled "Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof") was filed by Sofar on Jul 21, 2010. The application was issued on Aug 3, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TILLOTTS PHARMAFeb 28, 2019BECK GREENER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2461802

SOFAR
Application Number
EP10752187A
Filing Date
Jul 21, 2010
Status
Patent Maintained As Amended
Jul 1, 2022
Publication Date
Aug 3, 2022